Completed NA INTERVENTIONAL 2-arm NCT00460343

Pharmacy Implementation Trial: Adherence to Antihypertensive Therapy

Implementation of a Pharmacy-Intervention to Establish and if Necessary Improve Adherence to Antihypertensive Therapy. A Cluster Randomized Trial.

Sponsor: Radboud University Medical Center

Conditions Hypertension

Interventions control extensive implementation programme

Updated 6 times since 2017 Last updated: Jul 9, 2008 Started: Apr 30, 2007 Primary completion: May 31, 2008 Completion: Jun 30, 2008

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00460343, this NA trial focuses on Hypertension and remains completed. Sponsored by Radboud University Medical Center, it has been updated 6 times since 2007, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Mar 2022 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Mar 2022 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Apr 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Radboud University Medical Center
Scientific Institute for Dutch Pharmacists, The Netherlands
Zorgverzekeraar CZ

Data source: Radboud University Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.